Flavonoids
Unnamed: 1
Unnamed: 2
Bioflavonoids





Synonym(s) and related species








Monograph
Interpretation
Citation
Aciclovir
The interaction between quercetin and aciclovir is based on experimental evidence only.
Yang ZG, Meng H, Zhang X, Li XD, Lv WL, Zhang Q. Effect of quercetin on the acyclovir intestinal absorption. Beijing Da Xue Xue Bao (2004) 36, 309–12.
Antibacterials
The interaction between flavonoids and antibacterials is based on experimental evidence only.
Xing J, Chen X, Sun Y, Luan Y, Zhong D. Interaction of baicalin and baicalein with antibiotics in the gastrointestinal tract. J Pharm Pharmacol (2005) 57, 743–50.


Wang X, Morris ME. Effects of the flavonoid chrysin on nitrofurantoin pharmacokinetics in rats: potential involvement of ABCG2. Drug Metab Dispos (2007) 35, 268– 74.
Anticoagulant or Antiplatelet drugs
The interaction between flavonoids and anticoagulant or antiplatelet drugs is based on a prediction only.
Murphy KJ, Chronopoulos AK, Singh I, Francis MA, Moriarty H, Pike MJ, Turner AH, Mann NJ, Sinclair AJ. Dietary flavanols and procyanidin oligomers from cocoa (Theobroma cacao) inhibit platelet function. Am J Clin Nutr (2003) 77, 1466–73.


Hubbard GP, Wolffram S, de Vos R, Bovy A, Gibbins JM, Lovegrove JA. Ingestion of onion soup high in quercetin inhibits platelet aggregation and essential components of the collagen-stimulated platelet activation pathway in man: a pilot study. Br J Nutr (2006) 96, 482–8.


Janssen K, Mensink RP, Cox FJJ, Harryvan JL, Hovenier R, Hollman PCH, Katan MB. Effects of the flavonoids quercetin and apigenin on hemostasis in healthy volunteers: results from an in vitro and a dietary supplement study. Am J Clin Nutr (1998) 67, 255– 62.


Conquer JA, Maiani G, Azzini E, Raguzzini A, Holub BJ. Supplementation with quercetin markedly increases plasma quercetin concentration without effect on selected risk factors for heart disease in healthy subjects. J Nutr (1998) 128, 593–7.


Pearson DA, Paglieroni TG, Rein D, Wun T, Schramm DD, Wang JF, Holt RR, Gosselin R, Schmitz HH, Keen CL. The effects of flavanol-rich cocoa and aspirin on ex vivo platelet function. Thromb Res (2002) 106, 191–7.


Nardini M, Natella F, Scaccini C. Role of dietary polyphenols in platelet aggregation. A review of the supplementation studies. Platelets (2007) 18, 224–43.
Benzodiazepines
In a study, tangerine juice, containing tangeretin, did not affect the pharmacokinetics of midazolam. However, grapefruit juice, which contains different flavonoids, does increase levels of some benzodiazepines.
Backman JT, Mäenpää J, Belle DJ, Wrighton SA, Kivistö KT, Neuvonen PJ. Lack of correlation between in vitro and in vivo studies on the effects of tangeretin and tangerine juice on midazolam hydroxylation. Clin Pharmacol Ther (2000) 67, 382–90.


Xu Z, Wang F, Tsang SY, Ho KH, Zheng H, Yuen CT, Chow CY, Xue H. Anxiolytic-like effect of baicalin and its additivity with other anxiolytics. Planta Med (2006) 72, 189– 92.


Fernández SP, Wasowski C, Paladini AC, Marder M. Synergistic interaction between hesperidin, a natural flavonoid, and diazepam. Eur J Pharmacol (2005) 512, 189–98.


Ha HR, Chen J, Leuenberger PM, Freiburghaus AU, Follath F. In vitro inhibition of midazolam and quinidine metabolism by flavonoids. Eur J Clin Pharmacol (1995) 48, 367–71.
Caffeine
Naringin does not appear to affect the pharmacokinetics of caffeine.
Ballard TL, Halaweish FT, Stevermer CL, Agrawal P, Vukovich MD. Naringin does not alter caffeine pharmacokinetics, energy expenditure, or cardiovascular haemodynamics in humans following caffeine consumption. Clin Exp Pharmacol Physiol (2006) 33, 310–14.


Maish WA, Hampton EM, Whitsett TL, Shepard JD, Lovallo WR. Influence of grapefruit juice on caffeine pharmacokinetics and pharmacodynamics. Pharmacotherapy (1996) 16, 1046–52.


Fuhr U, Klittich K, Staib AH. Inhibitory effect of grapefruit juice and its bitter principal, naringenin, on CYP1A2 dependent metabolism of caffeine in man. Br J Clin Pharmacol (1993) 35, 431–6.
Calcium-channel blockers
Supplements of specific citrus bioflavonoids do not appear to affect the pharmacokinetics of calcium-channel blockers to a clinically relevant extent.
Bailey DG, Arnold JMO, Munoz C, Spence JD. Grapefruit juice-felodipine interaction: mechanism, predictability, and effect of naringin. Clin Pharmacol Ther (1993) 53, 637– 42.


Bailey DG, Kreeft JH, Munoz C, Freeman DJ, Bend JR. Grapefruit juice-felodipine interaction: effect of naringin and 6’,7’-dihydroxybergamottin in humans. Clin Pharmacol Ther (1998) 64, 248–56.


Rashid J, McKinstry C, Renwick AG, Dirnhuber M, Waller DG, George CF. Quercetin, an in vitro inhibitor of CYP3A, does not contribute to the interaction between nifedipine and grapefruit juice. Br J Clin Pharmacol (1993) 36, 460–3.


Bailey DG, Arnold JMO, Strong HA, Munoz C, Spence JD. Effect of grapefruit juice and naringin on nisoldipine pharmacokinetics. Clin Pharmacol Ther (1993) 54, 589–94.


Choi J-S, Han H-K. Pharmacokinetic interaction between diltiazem and morin, a flavonoid, in rats. Pharmacol Res (2005) 52, 386–91.


Choi J-S, Han H-K. Enhanced oral exposure of diltiazem by the concomitant use of naringin in rats. Int J Pharm (2005) 305, 122–8.


Choi JS, Burm JP. Enhanced nimodipine bioavailability after oral administration of nimodipine with morin, a flavonoid, in rabbits. Arch Pharm Res (2006) 29, 333–8.


Yeum C-H, Choi J-S. Effect of naringin pretreatment on bioavailability of verapamil in rabbits. Arch Pharm Res (2006) 29, 102–7.


Kim HJ, Choi JS. Effects of naringin on the pharmacokinetics of verapamil and one of its metabolites, norverapamil, in rabbits. Biopharm Drug Dispos (2005) 26, 295–300.


Choi J-S, Han H-K. The effect of quercetin on the pharmacokinetics of verapamil and its major metabolite, norverapamil, in rabbits. J Pharm Pharmacol (2004) 56, 1537– 42.


Bailey DG, Dresser GK, Kreeft JH, Munoz C, Freeman DJ, Bend JR. Grapefruitfelodipine interaction: effect of unprocessed fruit and probable active ingredients. Clin Pharmacol Ther (2000) 68, 468–77.
Ciclosporin
A study found that quercetin increased the bioavailability of ciclosporin.
Choi JS, Choi BC, Choi KE. Effect of quercetin on the pharmacokinetics of oral cyclosporine. Am J Health-Syst Pharm (2004) 61, 2406–9.


Satyanarayana PSV, Singh D, Chopra K. Quercetin, a bioflavonoid, protects against oxidative stress-related renal dysfunction by cyclosporine in rats. Methods Find Exp Clin Pharmacol (2001) 23, 175–81.


Hsiu S-L, Hou Y-C, Wang Y-H, Tsao C-W, Su S-F, Chao P-DL. Quercetin significantly decreased cyclosporin oral bioavailability in pigs and rats. Life Sci (2002) 72, 227–35.


Yang CY, Chao PDL, Hou YC, Tsai SY, Wen KC, Hsiu SL. Marked decrease of cyclosporin bioavailability caused by coadministration of ginkgo and onion in rats. Food Chem Toxicol (2006) 44, 1572–8.


Fang S-H, Hou Y-C, Chao P-DL. Pharmacokinetic and pharmacodynamic interactions of morin and cyclosporin. Toxicol Appl Pharmacol (2005) 205, 65–70.


Lai M-Y, Hsiu S-L, Hou Y-C, Tsai S-Y, Chao P-DL. Significant decrease of cyclosporine bioavailability in rats caused by a decoction of the roots of Scutellaria baicalensis. Planta Med (2004) 70, 132–7.


Tsai P-L, Tsai T-H. Pharmacokinetics of baicalin in rats and its interactions with cyclosporin A, quinidine and SKF-525A: a microdialysis study. Planta Med (2004) 70, 1069–74.
Digoxin
The interaction between flavonoids and digoxin is based on experimental evidence only.
Wang Y-H, Chao P-DL, Hsiu S-L, Wen K-C, Hou Y-C. Lethal quercetin-digoxin interaction in pigs. Life Sci (2004) 74, 1191–7.


Chung SY, Jang DS, Han A-R, Jang JO, Kwon Y, Seo E-K, Lee HJ. Modulation of Pglycoprotein-mediated resistance by kaempferol derivatives isolated from Zingiber zerumbet. Phytother Res (2007) 21, 565–9.


USDA Database for the flavonoid content of selected foods, Release 2.1. http:// www.nal.usda.gov/fnic/foodcomp/Data/Flav/Flav02-1.pdf (accessed 20/11/2008).


Kasper H, Zilly W, Fassl H, Fehle F. The effect of dietary fiber on postprandial serum digoxin concentration in man. Am J Clin Nutr (1979) 32, 2436–8.
Enalapril
The interaction between flavonoids and enalapril is based on experimental evidence only.
Li P, Callery PS, Gan L-S, Balani SK. Esterase inhibition by grapefruit juice flavonoids leading to a new drug interaction. Drug Metab Dispos (2007) 35, 1203–8.
Etoposide
The interaction between flavonoids and etoposide is based on experimental evidence only
Lo Y-L, Huang J-D. Comparison of effects of natural or artificial rodent diet on etoposide absorption in rats. In Vivo (1999) 13, 51–5.


Li X, Yun J-K, Choi J-S. Effects of morin on the pharmacokinetics of etoposide in rats. Biopharm Drug Dispos (2007) 28, 151–6.
Fexofenadine
Naringin and hesperidin may slightly reduce fexofenadine bioavailibility.
Bailey DG, Dresser GK, Leake BF, Kim RB. Naringin is a major and selective clinical inhibitor of organic anion-transporting polypeptide 1A2 (OATP1A2) in grapefruit juice. Clin Pharmacol Ther (2007) 81, 495–502.
Food; Milk
The addition of milk to tea did not alter the absorption of quercetin or kaempferol, or catechins, see Tea + Food, page 467.

Herbal medicines
No interactions found. Flavonoids are a very large family of polyphenolic compounds synthesised by plants that are common and widely distributed.

Irinotecan or Topotecan
Limited evidence suggests that high doses of chrysin are unlikely to cause an adverse interaction with irinotecan and possibly topotecan.
Tobin PJ, Beale P, Noney L, Liddell S, Rivory LP, Clarke S. A pilot study on the safety of combining chrysin, a non-absorbable inducer of UGT1A1, and irinotecan (CPT-11) to treat metastatic colorectal cancer. Cancer Chemother Pharmacol (2006) 57, 309–16.


Zhang S, Wang X, Sagawa K, Morris ME. Flavonoids chrysin and benzoflavone, potent breast cancer resistance protein inhibitors, have no significant effect on topotecan pharmacokinetics in rats or mdr1a/1b (-/-) mice. Drug Metab Dispos (2005) 33, 341–8.
Paclitaxel
The interaction between morin, naringin or quercetin and paclitaxel is based on experimental evidence only.
Choi B-C, Choi J-S, Han H-K. Altered pharmacokinetics of paclitaxel by the concomitant use of morin in rats Int J Pharm (2006) 323, 81–5.


Lim S-C, Choi J-S. Effects of naringin on the pharmacokinetics of intravenous paclitaxel in rats. Biopharm Drug Dispos (2006) 27, 443–7.


Choi J-S, Shin S-C. Enhanced paclitaxel bioavailability after oral coadministration of paclitaxel prodrug with naringin to rats. Int J Pharm (2005) 292, 149–56.


Choi J-S, Jo B-W, Kim Y-C. Enhanced paclitaxel bioavailability after oral administration of paclitaxel or prodrug to rats pretreated with quercetin. Eur J Pharm Biopharm (2004) 57, 313–18.
Quinine or Quinidine
The interaction between flavonoids and quinine or quinidine is based on experimental evidence only.
Zhang H, Wong CW, Coville PF, Wanwimolruk S. Effect of the grapefruit flavonoid naringin on pharmacokinetics of quinine in rats. Drug Metabol Drug Interact (2000) 17, 351–63.


Ho P-C, Saville DJ, Wanwimolruk S. Inhibition of human CYP3A4 activity by grapefruit flavonoids, furanocoumarins and related compounds. J Pharm Pharm Sci (2001) 4, 217–27.


Ha HR, Chen J, Leuenberger PM, Freiburghaus AU, Follath F. In vitro inhibition of midazolam and quinidine metabolism by flavonoids. Eur J Clin Pharmacol (1995) 48, 367–71.


Tsai P-L, Tsai T-H. Pharmacokinetics of baicalin in rats and its interactions with cyclosporin A, quinidine and SKF-525A: a microdialysis study. Planta Med (2004) 70, 1069–74.
Rosiglitazone
Quercetin does not appear to affect the pharmacokinetics of rosiglitazone.
Kim K-A, Park P-W, Kim H-K, Ha J-M, Park J-Y. Effect of quercetin on the pharmacokinetics of rosiglitazone, a CYP2C8 substrate, in healthy subjects. J Clin Pharmacol (2005) 45, 941–6.
Saquinavir
Quercetin does not appear to affect the pharmacokinetics of saquinavir.
DiCenzo R, Frerichs V, Larppanichpoonphol P, Predko L, Chen A, Reichman R, Morris M. Effect of quercetin on the plasma and intracellular concentrations of saquinavir in healthy adults. Pharmacotherapy (2006) 26, 1255–61.
Statins
The interaction between flavonoids and statins is based on experimental evidence only.
Li P, Callery PS, Gan L-S, Balani SK. Esterase inhibition by grapefruit juice flavonoids leading to a new drug interaction. Drug Metab Dispos (2007) 35, 1203–8.


Le Goff N, Koffel JC, Vandenschrieck S, Jung L, Ubeaud G. Comparison of in vitro hepatic models for the prediction of metabolic interaction between simvastatin and naringenin. Eur J Drug Metab Pharmacokinet (2002) 27, 233–41.


Ubeaud G, Hagenbach J, Vandenschrieck S, Jung L, Koffel JC. In vitro inhibition of simvastatin metabolism in rat and human liver by naringenin. Life Sci (1999) 65, 1403– 12.
 Tamoxifen
The interaction between flavonoids and tamoxifen is based on experimental evidence only.
Rosengren RJ. Catechins and the treatment of breast cancer: possible utility and mechanistic targets. IDrugs (2003) 6, 1073–8.


Bracke ME, Depypere HT, Boterberg T, Van Marck VL, Vennekens KM, Vanluchene E, Nuytinck M, Serreyn R, Mareel MM. Influence of tangeretin on tamoxifen’s therapeutic benefit in mammary cancer. J Natl Cancer Inst (1999) 91, 354–9.


Shin S-C, Choi J-S, Li X. Enhanced bioavailability of tamoxifen after oral administration of tamoxifen with quercetin in rats. Int J Pharm (2006) 313, 144–9.
